Tapestry, Capri file notice to appeal court decision blocking their $8.5 billion merger

Date:

Share post:


Tapestry and Capri Holdings have filed their notice to jointly appeal the decision by a U.S. District judge to temporarily halt the merger between the makers of Coach and Michael Kors handbags, according to a court filing Monday

NEW YORK — Tapestry Inc. and Capri Holdings Ltd. have filed their notice to jointly appeal the decision by a U.S. District judge to temporarily halt the merger between the makers of Coach and Michael Kors handbags, according to a court filing Monday.

In her ruling Thursday, U.S. District Judge Jennifer Rochon noted that Tapestry and Capri are “close competitors” and that the merger would result in “the loss of head-to-head competition” and raise prices for shoppers.

The ruling came six months after the Federal Trade Commission sued to block Tapestry’s $8.5 billion acquisition of Capri, saying that the deal would eliminate direct competition between the fashion companies’ brands in the so-called affordable luxury handbag arena.

Tapestry has been on an acquisition binge for the past several years, and already owns Kate Spade New York, Stuart Weitzman and Coach. Capri owns the Versace, Michael Kors and Jimmy Choo brands.

The agency also said that the deal announced in August 2023 threatens to eliminate the incentive for the two companies to vie for employees and could depress employees’ wages and workplace benefits. The combined Tapestry and Capri would employ roughly 33,000 people worldwide, the agency said.

Tapestry said in an emailed statement to The Associated Press on Thursday that the decision granting the FTC’s request for a preliminary injunction was “disappointing” and “incorrect on the law and the facts.”



Source link

Lisa Holden
Lisa Holden
Lisa Holden is a news writer for LinkDaddy News. She writes health, sport, tech, and more. Some of her favorite topics include the latest trends in fitness and wellness, the best ways to use technology to improve your life, and the latest developments in medical research.

Recent posts

Related articles

What's next for EVs under President Trump?

WASHINGTON -- President Donald Trump signed an executive order promising to eliminate what he incorrectly labels “the...

Rosy December for small business sales, but restaurants are left out

NEW YORK -- Small businesses had a merry December, as shoppers wrapped up their holiday shopping.That's according...

Global shares trade mixed in a muted reaction to the U.S. inauguration

TOKYO -- Global shares were mixed in a muted reaction Tuesday to the inauguration of U.S. President...

Sequel to Prince Harry's feud with British tabloids begins in high-stakes trial

LONDON -- The sequel to Prince Harry vs. the British tabloids begins Tuesday in a high-stakes pitting...

Dozens of firms pull ads from Japanese network over sex scandal linked to its staff and celebrity

TOKYO -- Dozens of major Japanese companies have pulled their commercials on Fuji Television amid allegations company...

Canada relieved Trump doesn’t impose tariffs on the major US trading partner on first day

TORONTO -- Canadian leaders expressed relief Monday that broad tariffs were not applied to Canadian products on...

Prada offers savage, instinctive menswear during Milan Fashion Week

MILAN -- MILAN (AP) — Miuccia Prada and her co-creative director Raf Simons described the latest Prada...

Stock market today: Asian shares track Wall St's strong finish ahead of Trump's inauguration

BANGKOK -- Asian shares advanced early Monday after U.S. stock indexes rallied to close out their best...